Credit Suisse Ag Genfit S.A. Transaction History

Credit Suisse Ag

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$3.09 - $4.25 $7,051 - $9,698	2,282 New	2,282 $7,000
Q1 2022 May 16, 2022	SELL	$3.14 - $5.04 $34,263 - $54,996	-10,912 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.01 - $5.65 $32,845 - $61,652	10,912 New	10,912 $55,000

49.2K

Ticker GNFT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,815,500
Market Cap $252M
Description
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.